Evidence map›Paper›PMID 26933028›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies.

Vera von Kalckreuth, Frank Konings, Peter Aaby, Yaw Adu-Sarkodie, Mohammad Ali, Abraham Aseffa, Stephen Baker, Robert F Breiman, Morten Bjerregaard-Andersen, John D Clemens and 22 more

Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07416461 (Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-Typhoidal Salmonella Disease), which is not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07416461 recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-Typhoidal Salmonella Disease (VINS)

TypeobservationalSponsorInternational Vaccine InstituteRan2025 to 2027Enrolled10,000ConditionsInvasive Non-Typhoidal Salmonella Disease, Malaria, Malaria VaccineArmsR21/Matrix-M malaria vaccine
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pathogens That Cause Acute Febrile Illness Among Children and Adolescents in Burkina Faso, Madagascar, and Sudan.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Vera von KalckreuthInternational Vaccine Institute, Seoul, Republic of Korea.
Frank KoningsInternational Vaccine Institute, Seoul, Republic of Korea.
Peter AabyBandim Health Project, Bissau, Guinea-Bissau.
Yaw Adu-SarkodieKumasi Centre for Collaborative Research in Tropical Medicine School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Mohammad AliInternational Vaccine Institute, Seoul, Republic of Korea Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abraham AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Stephen BakerOxford University Clinical Resarch Unit, Ho Chi Minh City, Vietnam.
Robert F BreimanCenters for Disease Control and Prevention, Nairobi, Kenya Global Health Institute, Emory University, Atlanta, Georgia.
Morten Bjerregaard-AndersenBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
John D ClemensInternational Vaccine Institute, Seoul, Republic of Korea International Centre for Diarrheal Disease Research, Dhaka, Bangladesh.
John A CrumpDivision of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina Kilimanjaro Christian Medical Centre, Moshi, Tanzania Centre for International Health, University of Otago, Dunedin, New Zealand.
Ligia Maria Cruz EspinozaInternational Vaccine Institute, Seoul, Republic of Korea.
Jessica Fung DeerinInternational Vaccine Institute, Seoul, Republic of Korea.
Nagla GasmelseedUniversity of Gezira, Wad Medani, Sudan.
Amy Gassama SowInstitute Pasteur Senegal Université Cheikh Anta Diop de Dakar, Senegal.
Justin ImInternational Vaccine Institute, Seoul, Republic of Korea.
Karen H KeddyNational Institute for Communicable Diseases School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Leonard CosmasCenters for Disease Control and Prevention, Nairobi, Kenya.
Jürgen MayDepartment of Infection Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg.
Christian G MeyerInstitute of Tropical Medicine, Eberhard-Karls University Tübingen, Germany.
Eric D MintzNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Joel M MontgomeryCenters for Disease Control and Prevention, Nairobi, Kenya.
Beatrice OlackKenya Medical Research Institute, Nairobi, Kenya.
Gi Deok PakInternational Vaccine Institute, Seoul, Republic of Korea.
Ursula PanznerInternational Vaccine Institute, Seoul, Republic of Korea.
Se Eun ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Raphaël RakotozandrindrainyUniversity of Antananarivo, Madagascar.
Heidi Schütt-GerowittInstitute of Medical Microbiology, University of Cologne, Germany.
Abdramane Bassiahi SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Burkina Faso.
Michelle R WarrenInternational Vaccine Institute, Seoul, Republic of Korea.
Thomas F WierzbaInternational Vaccine Institute, Seoul, Republic of Korea.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
HIV/AIDS Clinical Trials UnitU01AI069484 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2007 to 2011
$14.6M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Biotechnology and Biological Sciences Research Council BB/J010367FIC NIH HHS R01 TW009237FIC NIH HHS R01TW009237FIC NIH HHS R24 TW007988NIAID NIH HHS P30 AI064518NIAID NIH HHS U01 AI062563NIAID NIH HHS U01 AI067854NIAID NIH HHS U01 AI069484PHS HHS D43 PA-03018Wellcome Trust 100087Wellcome Trust 100087/Z/12/Z
6 · The paper itself

Abstract

backgroundNew immunization programs are dependent on data from surveillance networks and disease burden estimates to prioritize target areas and risk groups. Data regarding invasive Salmonella disease in sub-Saharan Africa are currently limited, thus hindering the implementation of preventive measures. The Typhoid Fever Surveillance in Africa Program (TSAP) was established by the International Vaccine Institute to obtain comparable incidence data on typhoid fever and invasive nontyphoidal Salmonella (iNTS) disease in sub-Saharan Africa through standardized surveillance in multiple countries.

methodsStandardized procedures were developed and deployed across sites for study site selection, patient enrolment, laboratory procedures, quality control and quality assurance, assessment of healthcare utilization and incidence calculations.

resultsPassive surveillance for bloodstream infections among febrile patients was initiated at thirteen sentinel sites in ten countries (Burkina Faso, Ethiopia, Ghana, Guinea-Bissau, Kenya, Madagascar, Senegal, South Africa, Sudan, and Tanzania). Each TSAP site conducted case detection using these standardized methods to isolate and identify aerobic bacteria from the bloodstream of febrile patients. Healthcare utilization surveys were conducted to adjust population denominators in incidence calculations for differing healthcare utilization patterns and improve comparability of incidence rates across sites.

conclusionsBy providing standardized data on the incidence of typhoid fever and iNTS disease in sub-Saharan Africa, TSAP will provide vital input for targeted typhoid fever prevention programs.

Indexed as

Public Health SurveillanceTyphoid FeverAdolescentAfrica South of the SaharaChildChild, PreschoolHumansInfantInfant, NewbornAfricainvasive Salmonella diseasemethodologysurveillancetyphoid fever

Identifiers

PMID26933028
PMCPMC4772831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.